MedTrace Logo

ABTHERA ADVANCE™ Use Without Wittman Patch

NCT04986943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2023-08-31

No results posted yet for this study

Summary

The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients requiring open abdomen due to necrotizing pancreatitis. The institutions traditional approach is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE has shown in vitro to have improved tension on the abdominal wall that may obviate the need for costly Wittmann patch placement.

Conditions

  • Necrotizing Pancreatitis

Interventions

DEVICE

Using ABTHERA Advance without a Wittmann Patch

In this group, patients will be receiving only the ABTHERA Advance product, without the use of the Wittmann Patch

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Dionisios Vrochides, MD, PhD · Wake Forest University Health Sciences

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-12
Primary Completion
2022-03-28
Completion
2023-03-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04986943 on ClinicalTrials.gov